CClinicalTrials.gg
WithdrawnNCT01986816ROI-LGBPUpdated Feb 15, 2019

Return on Investment on Lap Gastric Bypass Regarding Quality of Life

An observational study in Obesity, sponsored by Lund University. Withdrawn at 1 site in Sweden. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2019-02-15.

Sponsored by Lund University · Observational

Why this study was withdrawn
Investigaotr no longer at LU.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to investigate the cost of treatment and adverse efffects therof corresponds to quality of life improvements and expected wheightloss.

02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • Obesity
  • Bariatric surgery
  • Laparoscopic gastric bypass
  • Quality of life
  • QALY
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,695 are open to participants now.

Browse Obesity studies →

Lead sponsor

Lund University is the lead sponsor of 230 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Populutaion af morbid obese patients with BMI of 35 or more eligible for bariatric surgery

Inclusion criteria

  • BMI > 35
  • age 18-60 years

Exclusion criteria

Exclusion Criteria:

  • Prior bariatric surgery
  • Prior gastric surgery
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Significant wheigtloss

    Time frame: 1 year

Secondary outcomes

  1. Quality of life improvement

    Time frame: 3 months and 12 months post surgery

07

Study locations

1 site
  • Kalmar County Hospital
    Kalmar, Kalmar Län 391 85, Sweden
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01986816
Lead sponsor
Lund University
Collaborators
Landstinget i Kalmar Län
Responsible party
Johan Berggren (MD, Lund University) — Principal investigator
First posted
Nov 19, 2013
Start date
Apr 2014
Primary completion
Dec 2015 (estimated)
Completion
Dec 2016 (estimated)
Last update
Feb 15, 2019

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion